We are live on ! Find out more
GHSI

Guardion Health Sciences, Inc. Common Stock
GHSI

Delisted

GHSI was delisted on the 11th of October, 2024.

Back to rankings

10 hedge funds and large institutions have $314K invested in Guardion Health Sciences, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

42% less capital invested

Capital invested by funds: $546K → $314K (-$231K)

55% less funds holding

Funds holding: 22 → 10 (-12)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 11

Holders
10
Holders Change
-12
Holders Change %
-54.55%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
2
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$13.3K
2
BlackRock
BlackRock
New York
+$7
3
Citigroup
Citigroup
New York
+$7
4
Wells Fargo
Wells Fargo
California
+$7

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$41.8K
2
Millennium Management
Millennium Management
New York
-$29K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$25K
4
UBS Group
UBS Group
Switzerland
-$22.9K
5
State Street
State Street
Massachusetts
-$19.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$216K +$13.3K +2,005 +6%
BlackRock
2
BlackRock
New York
$61.3K +$7 +1 +0%
Barclays
3
Barclays
United Kingdom
$30.6K – – –
Morgan Stanley
4
Morgan Stanley
New York
$4.03K -$27 -4 -0.6%
Citigroup
5
Citigroup
New York
$2.28K +$7 +1 +0.3%
S
6
SignatureFD
Georgia
$122 – – –
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Quebec, Canada
$104 – – –
Wells Fargo
8
Wells Fargo
California
$55 +$7 +1 +13%
Osaic Holdings
9
Osaic Holdings
Arizona
$37 – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
– -$41.8K -5,766 Closed
Millennium Management
11
Millennium Management
New York
– -$29K -3,930 Closed
Geode Capital Management
12
Geode Capital Management
Massachusetts
– -$25K -3,397 Closed
UBS Group
13
UBS Group
Switzerland
– -$22.9K -3,052 Closed
State Street
14
State Street
Massachusetts
– -$19.6K -2,699 Closed
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
– -$17.1K -2,350 Closed
Northern Trust
16
Northern Trust
Illinois
– -$8.37K -1,153 Closed
Citadel Advisors
17
Citadel Advisors
Florida
– -$6.8K -937 Closed
TRCT
18
Tower Research Capital (TRC)
New York
– -$5.96K -898 -100%
Jane Street
19
Jane Street
New York
– -$4.03K -555 Closed
HF
20
HRT Financial
New York
– -$3K -440 Closed
RJFSA
21
Raymond James Financial Services Advisors
Florida
– -$2.18K -300 Closed

GHSI Hedge Fund Activity: Q1 2023 in Review

10 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q1 2023, worth a combined $314K — down 42% from $546K a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of GHSI and 0 opened new positions — a net loss of 11 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $13.3K. The largest seller was Vanguard Group, exiting entirely with an estimated $41.8K sold.

  • 10 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q1 2023, down from 22 in Q4 2022.
  • Funds reported $314K of Guardion Health Sciences, Inc. Common Stock stock for Q1 2023, down 42% quarter-over-quarter.
  • 0 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q1 2023 and 11 closed out, a net change of -11 holders.
  • The largest Guardion Health Sciences, Inc. Common Stock buyer in Q1 2023 was Renaissance Technologies, an estimated $13.3K added.
  • The largest Guardion Health Sciences, Inc. Common Stock seller in Q1 2023 was Vanguard Group, an estimated $41.8K sold.

Based on aggregated 13F filings for Q1 2023.